IsoPlexis to Participate in Three Upcoming Investor Conferences

Rhea-AI Summary

IsoPlexis Corporation (Nasdaq: ISO), known as the Superhuman Cell Company, announced its participation in several upcoming investor conferences. These include the 11th Annual SVB Leerink Global Healthcare Conference on February 16, 2022, the Cowen 42nd Annual Health Care Conference on March 9, 2022, and the Barclays Global Healthcare Conference on March 15, 2022. Live and archived webcasts will be available on the company's website. IsoPlexis' innovative systems help researchers understand disease progression and treatment efficacy, and have received accolades from major publications.

BRANFORD, Conn., Feb. 11, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company, today announced the company will be participating in the following investor conferences.

• 11^th Annual SVB Leerink Global Healthcare Conference, Virtual
  Fireside Chat on Wednesday, February 16^th at 7:00 a.m. Pacific Time / 10:00 a.m. Eastern Time
  
  
• Cowen 42^nd Annual Health Care Conference, Virtual
  Fireside Chat on Wednesday, March 9^th at 6:10 a.m. Pacific Time / 9:10 a.m. Eastern Time
  
  
• Barclays Global Healthcare Conference
  Fireside Chat on Tuesday, March 15^th at 8:15 a.m. Pacific Time / 11:15 a.m. Eastern Time

Interested parties may access live and archived webcasts on the “Investors” section of the company website at: www.isoplexis.com.

About IsoPlexis

IsoPlexis is the Superhuman Cell company.

IsoPlexis’ systems uniquely identify a comprehensive range of multifunctional single cells, i.e. the superhero cells in the human body. These cells enable researchers to understand and predict disease progression, treatment resistance and therapeutic efficacy to advance all of human health.

IsoPlexis has been named Top Innovation or Design by The Scientist Magazine, Fierce, BIG Innovation, Red Dot and multiple others. The IsoPlexis platform is used globally by researchers, including those at the top 15 global pharmaceutical companies and at two-thirds of leading U.S. comprehensive cancer centers.

Investor Contact
investors@isoplexis.com

Press Contact
press@isoplexis.com

FAQ

What investor conferences is IsoPlexis attending in 2022?

IsoPlexis is attending the SVB Leerink Global Healthcare Conference on February 16, the Cowen Health Care Conference on March 9, and the Barclays Global Healthcare Conference on March 15.

When is IsoPlexis' fireside chat at the SVB Leerink Conference?

The fireside chat at the SVB Leerink Global Healthcare Conference is scheduled for February 16, 2022, at 7:00 a.m. Pacific Time / 10:00 a.m. Eastern Time.

Where can I access IsoPlexis' conference webcasts?

Live and archived webcasts of IsoPlexis' conferences can be accessed on the 'Investors' section of their website.

What is the focus of IsoPlexis' technology?

IsoPlexis' technology focuses on identifying multifunctional single cells to help researchers predict disease progression and treatment efficacy.

Has IsoPlexis received any awards or recognitions?

Yes, IsoPlexis has been recognized as Top Innovation or Design by The Scientist Magazine, Fierce, BIG Innovation, and others.